Directory

>

Mohammad Shadid

avatar

Mohammad Shadid

Vice President, Translational Sciences | Korro Bio, Inc.

Cambridge, Massachusetts, United States

View contact details (it's free)

Mohammad Shadid

Summary

Mohammad Shadid is a seasoned executive in the pharmaceutical industry, currently serving as Vice President and Head of Translational Sciences at Korro Bio. With a strong background in drug metabolism and pharmacokinetics, he has successfully led the transition of drug assets from early research to phase 1 clinical trials, coauthoring crucial regulatory submissions. His leadership in managing multiple CROs and overseeing significant budgets highlights his project management expertise. Mohammad is also recognized for his commitment to diversity, inclusion, and equity within organizations, demonstrating a holistic approach to leadership. His academic credentials, including a Ph.D. in Drug Metabolism and Pharmacokinetics, underpin his technical expertise. He has authored numerous publications, contributing to advancements in drug development and safety assessments. His strategic insight and cross-functional collaboration have made significant impacts on therapeutic pipelines.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Sustainability

Organisational experience

Corporate Experience

Mohammad Shadid

Work Experience

company logo

Vice President, Translational Sciences at

Korro Bio, Inc.

January 2023 - Present

company logo

Executive Director, Head of Nonclinical Development at

Aruvant

January 2022 - January 2023

company logo

Senior Director-Nonclinical Development at

Aruvant

January 2021 - January 2022

company logo

Translational Development Lead at

Sarepta Therapeutics

January 2019 - January 2021

company logo

Nonclinical Development Lead at

Sarepta Therapeutics

January 2018 - January 2019

company logo

DMPK Lead at

Biogen

January 2016 - January 2017

company logo

Scientist: Drug Metabolism & Pharmacokinetics (DMPK) at

Takeda Pharmaceuticals America, Inc.

January 2008 - January 2016

Logos provided by Logo.dev

Mohammad Shadid

Education

Cornell Johnson Graduate School of Management, Master Of Business Administration (Mba)

Jordan University of Science and Technology, Applied Chemistry

Frequently Asked Questions about Mohammad Shadid

What is Mohammad Shadid email address?

Mohammad Shadid's primary email address is ******@mpi.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mohammad Shadid work for?

Mohammad Shadid is a Vice President, Translational Sciences at Korro Bio, Inc., a company specializing in Commercial physical research.

Where Mohammad Shadid graduated from?

Mohammad Shadid holds a degree in Strategy, General Management from Cornell Johnson Graduate School of Management.

How can I directly contact Mohammad Shadid?

To contact Mohammad Shadid directly, you can use the email address ******@mpi.com. Complete contact information is available upon registration with Muraena.

Who is Mohammad Shadid?

Mohammad Shadid is a seasoned executive in the pharmaceutical industry, currently serving as Vice President and Head of Translational Sciences at Korro Bio. With a strong background in drug metabolism and pharmacokinetics, he has successfully led the transition of drug assets from early research to phase 1 clinical trials, coauthoring crucial regulatory submissions. His leadership in managing multiple CROs and overseeing significant budgets highlights his project management expertise. Mohammad is also recognized for his commitment to diversity, inclusion, and equity within organizations, demonstrating a holistic approach to leadership. His academic credentials, including a Ph.D. in Drug Metabolism and Pharmacokinetics, underpin his technical expertise. He has authored numerous publications, contributing to advancements in drug development and safety assessments. His strategic insight and cross-functional collaboration have made significant impacts on therapeutic pipelines.

Mohammad`s contact details

mail

******@mpi.com

***************@takeda.com

****@korrobio.com

Colleagues

Paul Peng

VP, Head of CMC

avatar
Stephanie Engels

SVP, HR People & Culture

avatar
Ram Aiyar

Director Board of Directors

avatar
Derek Erion

Vice President

avatar
Todd Chappell

Senior Vice President, Strategy And Portfolio Planning

avatar
David Peritt

Consultant

avatar
Marco Passini

Vice President, Head of CNS Biology

avatar
Jayati Vaidya

Vice President, Corporate Strategy & Portfolio Planning

avatar
Venkat Krishnamurthy

Senior Vice President, Head of Platform Research - RNA Editing

avatar
Vineet Agarwal

Chief Financial Officer

View Contact details (it's free)
Request Profile Removal